Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis

Nature Communications

Volumn 5, Issue , 2014, Pages

  Annibali, Daniela ^a,b   Whitfield, Jonathan R ^c,d   Favuzzi, Emilia ^b   Jauset, Toni ^c,d   Serrano, Erika ^c,d   Cuartas, Isabel ^c,d   Redondo Campos, Sara ^c,d   Folch, Gerard ^c,d   Gonzàlez Juncà, Alba ^c,d   Sodir, Nicole M ^a,e   Massó Vallés, Daniel ^c,d   Beaulieu, Marie Eve ^c,d   Swigart, Lamorna B ^a   Mc Gee, Margaret M ^f   Somma, Maria Patrizia ^b   Nasi, Sergio ^b   Seoane, Joan ^c,d,g   Evan, Gerard I ^e   Soucek, Laura ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; MYC PROTEIN, HUMAN; MYC PROTEIN, MOUSE; PROTEIN TYROSINE PHOSPHATASE 1B; PTPN1 PROTEIN, HUMAN; PTPN1 PROTEIN, MOUSE; SAE1 PROTEIN, HUMAN; SAE1 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

DISEASE TREATMENT; EXPERIMENTAL STUDY; HEALTH RISK; NERVOUS SYSTEM; NUMERICAL MODEL; PUBLIC HEALTH; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER CELL LINE; CELL CYCLE ARREST; CELL DIVISION; CONTROLLED STUDY; DISEASE COURSE; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; MOUSE; MULTINUCLEAR CELL; NONHUMAN; STEM CELL; XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE MODEL; GLIOBLASTOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; GLIOMA; HETEROGRAFTS; HUMANS; MICE; MICE, TRANSGENIC; MITOSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-MYC; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84907303705     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5632     Document Type: Article

References (35)

1. Kleihues, P., Burger, P. C. & Scheithauer, B. W. The new WHO classification of brain tumours. Brain Pathol. 3, 255-268 (1993). (Pubitemid 23276692)
2. Wen, P. Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507 (2008).
3. Huse, J. T. & Holland, E. C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 10, 319-331 (2010).
4. Guha, A., Feldkamp, M. M., Lau, N., Boss, G. & Pawson, A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15, 2755-2765 (1997). (Pubitemid 28004565)
5. Feldkamp, M. M., Lau, N., Rak, J., Kerbel, R. S. & Guha, A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int. J. Cancer 81, 118-124 (1999). (Pubitemid 29124206)
6. Vita, M. & Henriksson, M. The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16, 318-330 (2006). (Pubitemid 44311040)
7. Whitfield, J. R. & Soucek, L. Tumor microenvironment: becoming sick of Myc. Cell. Mol. Life Sci. 69, 931-934 (2012).
8. Orian, J. M. et al. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br. J. Cancer 66, 106-112 (1992).
9. Herms, J. W., von Loewenich, F. D., Behnke, J., Markakis, E. & Kretzschmar, H. A. c-myc oncogene family expression in glioblastoma and survival. Surg. Neurol. 51, 536-542 (1999). (Pubitemid 29218069)
10. Jensen, N. A. et al. Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. J. Biol. Chem. 278, 8300-8308 (2003). (Pubitemid 36800577)
11. Zheng, H. et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb. Symp. Quant. Biol. 73, 427-437 (2008).
12. Bidwell, 3rd G. L. et al. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS ONE 8, e55104 (2013).
13. Hu, Y. H., Kong, S. Q., Kong, H. B., Wu, J. L. & Chen, Z. Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells. Chin. Med. J. (Engl) 125, 2025-2031 (2012).
14. Soucek, L. et al. Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene 17, 2463-2472 (1998). (Pubitemid 28544716)
15. Soucek, L. et al. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res. 62, 3507-3510 (2002). (Pubitemid 34651400)
16. Soucek, L. et al. Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683 (2008).
17. Soucek, L. et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev. 27, 504-513 (2013).
18. Sodir, N. M. et al. Endogenous Myc maintains the tumor microenvironment. Genes Dev. 25, 907-916 (2011).
19. Ding, H. et al. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61, 3826-3836 (2001). (Pubitemid 32695000)
20. Shannon, P. et al. Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model. Am. J. Pathol. 167, 859-867 (2005). (Pubitemid 41216368)
21. Alcantara Llaguno, S. et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15, 45-56 (2009).
22. Assanah, M. et al. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J. Neurosci. 26, 6781-6790 (2006). (Pubitemid 44315239)
23. Sanai, N., Alvarez-Buylla, A. & Berger, M. S. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811-822 (2005).
24. Westphal, M. & Lamszus, K. Other experimental therapies for glioma. Recent Results Cancer Res. 171, 155-164 (2009).
25. Kerosuo, L. et al. Myc increases self-renewal in neural progenitor cells through Miz-1. J. Cell Sci. 121, 3941-3950 (2008).
26. Wang, J. et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE 3, e3769 (2008).
27. Clark, M. J. et al. U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet. 6, e1000832 (2010).
28. Kessler, J. D. et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353 (2012).
29. Amente, S., Lavadera, M. L., Palo, G. D. & Majello, B. SUMO-activating SAE1 transcription is positively regulated by Myc. Am. J. Cancer Res. 2, 330-334 (2012).
30. O'Donovan, D. S. et al. Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death. Cell Death Dis. 4, e468 (2013).
31. Dasso, M. Emerging roles of the SUMO pathway in mitosis. Cell Div. 3, 5 (2008).
32. Mondol, A. S., Tonks, N. K. & Kamata, T. Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C. Free Radic. Biol. Med. 67, 285-291 (2014).
33. Yip, S. C., Cotteret, S. & Chernoff, J. Sumoylated protein tyrosine phosphatase 1B localizes to the inner nuclear membrane and regulates the tyrosine phosphorylation of emerin. J. Cell Sci. 125, 310-316 (2012).
34. Dang, C. V. MYC on the path to cancer. Cell 149, 22-35 (2012).
35. Anido, J. et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 18, 655-668 (2010).